NO20033162L - Farmasöytisk tablett omfattende paroksetinmesylat - Google Patents

Farmasöytisk tablett omfattende paroksetinmesylat

Info

Publication number
NO20033162L
NO20033162L NO20033162A NO20033162A NO20033162L NO 20033162 L NO20033162 L NO 20033162L NO 20033162 A NO20033162 A NO 20033162A NO 20033162 A NO20033162 A NO 20033162A NO 20033162 L NO20033162 L NO 20033162L
Authority
NO
Norway
Prior art keywords
pharmaceutical tablet
paroxetine mesylate
paroxetine
mesylate
tablet
Prior art date
Application number
NO20033162A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033162D0 (no
Inventor
Theodorus Hendricus Ant Peters
Frans Van Dalen
Maria Jacobus Lemmens
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20033162D0 publication Critical patent/NO20033162D0/no
Publication of NO20033162L publication Critical patent/NO20033162L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033162A 2001-01-11 2003-07-10 Farmasöytisk tablett omfattende paroksetinmesylat NO20033162L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE20100529U DE20100529U1 (de) 2001-01-11 2001-01-11 Pharmazeutische Tablette umfassend Paroxetinmesylat
PCT/EP2001/015115 WO2002055062A2 (en) 2001-01-11 2001-12-20 Pharmaceutical tablet comprising paroxetine mesylate

Publications (2)

Publication Number Publication Date
NO20033162D0 NO20033162D0 (no) 2003-07-10
NO20033162L true NO20033162L (no) 2003-07-10

Family

ID=7951516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033162A NO20033162L (no) 2001-01-11 2003-07-10 Farmasöytisk tablett omfattende paroksetinmesylat

Country Status (9)

Country Link
US (1) US20040086559A1 (pl)
EP (1) EP1353652A2 (pl)
CZ (1) CZ20031899A3 (pl)
DE (1) DE20100529U1 (pl)
HU (1) HUP0600237A2 (pl)
NO (1) NO20033162L (pl)
PL (1) PL362701A1 (pl)
WO (1) WO2002055062A2 (pl)
ZA (1) ZA200305157B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
EP1675574A2 (en) * 2003-10-08 2006-07-05 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of paroxetine containing microcrystalline cellulose, prepared by wet granulation
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN102525966B (zh) * 2010-12-13 2016-06-29 江苏万全特创医药生物技术有限公司 一种含有帕罗西汀的片剂及其制备方法
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
GB201500512D0 (en) 2015-01-13 2015-02-25 Soe Health Ltd Therapeutic treatment methods, and apparatus for use therein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
EP1353652A2 (en) 2003-10-22
US20040086559A1 (en) 2004-05-06
WO2002055062A3 (en) 2003-03-13
CZ20031899A3 (en) 2004-03-17
ZA200305157B (en) 2004-08-17
PL362701A1 (pl) 2004-11-02
NO20033162D0 (no) 2003-07-10
WO2002055062A2 (en) 2002-07-18
HUP0600237A2 (en) 2006-11-28
DE20100529U1 (de) 2001-05-10

Similar Documents

Publication Publication Date Title
IS7010A (is) Lyfjaform ókristallaðs nelfinavir mesylate
EE200300416A (et) Ravimvorm
NO20033384L (no) Farmasoytisk formulering
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033556L (no) Farmasöytiske formuleringer
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
PT1501534E (pt) Formulacoes farmaceuticas
KR20050009999A (ko) 약제학적 제제
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DE60220162D1 (de) Tablettenförmige brühe
NO20035627D0 (no) Farmasöytisk formulering
NO20035315D0 (no) Farmasöytiske kombinasjoner
FI20022128L (fi) Farmaseuttinen koostumus
DE50209245D1 (de) Neuroprotektives medikament
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20033162D0 (no) Farmasoytisk tablett omfattende paroksetinmesylat
DE10291905D2 (de) Pharmazeutische Zusammensetzung
DE10107261B4 (de) Pharmazeutische Zusammensetzung
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
UA5530S (uk) Таблетка фармацевтична
AU2002235803A1 (en) Pharmaceutical tablet comprising paroxetine mesylate
NO20041236L (no) Farmasoytisk formulering
SE0103116D0 (sv) Pharmaceutical combination
SE0102823D0 (sv) New drug

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application